Use of TC-325 Hemostatic Powder as a Rescue Monotherapy for Management of Rectal Variceal Bleed

Authors

Amel Tabet Aoul, HCA HealthcareFollow
Vamsee Mupparuju, HCA HealthcareFollow
Jonathan Cirillo, HCA HealthcareFollow
Sreekanth Chandrupatla, HCA HealthcareFollow
Jeffrey Jordan, HCA HealthcareFollow
Maria A. Castano, HCA HealthcareFollow
Olugbenga Oyesanmi, HCA HealthcareFollow

Division

West Florida

Hospital

Citrus Memorial Hospital

Document Type

Case Report

Publication Date

6-20-2024

Keywords

hemostasis

Disciplines

Digestive System Diseases | Gastroenterology | Internal Medicine | Medicine and Health Sciences

Abstract

The use of the endoscopic hemostatic powder TC-325 as a rescue monotherapy or as an adjunct agent in achieving hemostasis has been studied in upper gastrointestinal variceal bleeds and nonvariceal lower gastrointestinal bleeds with promising results. In this report, we describe a case of a successful use of TC-325 as rescue monotherapy to manage rectal variceal bleeding in a patient with alcohol-related cirrhosis with no report of bleeding recurrence and no side effects within the first 7 days, 30 days, or 6 months.

Publisher or Conference

ACG Case Reports Journal

Recommended Citation

Tabet Aoul A, Mupparuju V, Cirillo J, et al. Use of TC-325 Hemostatic Powder as a Rescue Monotherapy for Management of Rectal Variceal Bleed. ACG Case Rep J. 2024;11(6):e01391. doi:10.14309/crj.0000000000001391